SHAREHOLDERS' EQUITY | 6. SHAREHOLDERS’ EQUITY Stock Compensation Plans We have outstanding equity awards under a 2013 Omnibus Stock and Incentive Plan (the “2013 Plan”), a 2007 Omnibus Stock and Incentive Plan (the “2007 Plan”) and a 2002 Omnibus Stock and Incentive Plan (the “2002 Plan,” and along with the 2013 Plan and 2007 Plan, the “Plans”), previously approved by our shareholders. We record stock-based compensation expense related to stock options, restricted stock and restricted stock units over the requisite service period based on the fair value of the awards on the grant date. We record stock-based compensation expense related to cash-settled stock appreciation rights (“SARs”) over the requisite service period based on the fair value of the awards at the end of each reporting period. For the three months ended December 31, 2016 and 2015, we recorded stock-based compensation expense of $1.5 million and $1.2 million, respectively, and for the nine months ended December 31, 2016 and 2015, we recorded stock-based compensation expense of $3.7 million and $3.3 million, respectively, which has been included in general and administrative expenses in the accompanying Consolidated Statements of Operations. At December 31, 2016, we had $8.0 million of unrecognized compensation costs related to non-vested Stock Options The following table summarizes the stock option transactions under the Plans for the nine months ended December 31, 2016: Shares Weighted Weighted Aggregate (1) Options outstanding at March 31, 2016 678,209 $ 30.08 Granted 344,169 16.62 Cancelled (42,980 ) 26.26 Expired (63,908 ) 38.13 Options outstanding at December 31, 2016 915,490 $ 24.62 7.66 years $ 275 Exercisable at December 31, 2016 424,620 $ 27.71 6.22 years $ 263 (1) The aggregate intrinsic value is based on the difference between the exercise price and our December 31, 2016 common share market value for in-the-money Restricted Stock The following tables summarize restricted stock and restricted stock unit award activity under the Plans for the nine months ended December 31, 2016: Restricted Shares Shares Weighted Non-vested 39,863 $ 22.98 Granted 1,179 16.74 Vested (10,500 ) 33.46 Forfeited (3,400 ) 27.04 Non-vested 27,142 $ 18.08 Restricted Stock Units Shares Weighted Non-vested 186,258 $ 24.79 Granted 59,993 16.56 Vested (37,892 ) 34.85 Forfeited (39,140 ) 19.20 Non-vested 169,219 $ 20.78 Cash-Settled Stock Appreciation Rights Cash-settled SARs are valued using the Black-Scholes option-pricing model on the date of grant and are subsequently remeasured at each reporting period based on a revised Black-Scholes value until they are exercised. There were no cash-settled SARs granted or forfeited during the nine months ended December 31, 2016. We recognized $0.1 million and $0.2 million of stock-based compensation expense related to previously granted cash-settled SARs during the three and nine months ended December 31, 2016, respectively. Accrued expense for these awards was $0.3 million at December 31, 2016, which was recorded within other liabilities in the accompanying Consolidated Balance Sheets. Net Earnings (Loss) Per Share Our basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of outstanding common shares. Our diluted weighted average shares outstanding includes common shares and common share equivalents relating to stock options and restricted stock units, when dilutive. Options to purchase 857,433 and 505,925 shares of common stock with weighted average exercise prices of $27.75 and $36.38 were outstanding during the three months ended December 31, 2016 and 2015, respectively, and options to purchase 863,095 and 392,513 shares of common stock with weighted average exercise prices of $27.28 and $37.39 were outstanding during the nine months ended December 31, 2016 and 2015, respectively, but were excluded from the computation of common share equivalents because they were anti-dilutive. Weighted average shares outstanding consists of the following for the three and nine months ended December 31, 2016 and 2015 (in thousands): Three Months Ended Nine Months Ended 2016 2015 2016 2015 Weighted average number of common shares outstanding 13,052 13,006 13,049 12,983 Dilutive effect of option plan — — — 164 Common and potential shares outstanding – diluted 13,052 13,006 13,049 13,147 Accumulated Other Comprehensive Loss The components of the changes in accumulated other comprehensive loss during the following periods were as follows ($ in thousands): Nine Months Ended December 31, 2016 2015 Accumulated other comprehensive loss, beginning $ (10,184 ) $ (7,142 ) Foreign currency translation adjustments (1,509 ) 332 Unrealized gain on derivative instruments, net of tax 2,715 165 Accumulated other comprehensive loss, ending $ (8,978 ) $ (6,645 ) The unrealized gain on derivative instruments for the nine months ended December 31, 2016 and 2015 were net of tax expense of $1.6 million and $0.1 million, respectively. There is no tax impact on foreign currency translation adjustments, as the earnings are considered permanently reinvested. |